论文部分内容阅读
哈药集团中药有限公司是哈药集团的所属子公司,是哈药集团的中药粉针生产基地,也是亚洲最大的中药粉针生产公司,年工业总产量10592万盒瓶,实现销售收入40976万元、利润6482万元、纳税4069万元。在国内众多药企竞相发展中药粉针剂产业的形势下,哈药集团中药有限公司为进一步扩大技术和规
Harbin Pharmaceutical Group Co., Ltd. is a subsidiary of Harbin Pharmaceutical Group, is the Harbin Pharmaceutical Group of Chinese medicine powder production base, is Asia’s largest powder production company of traditional Chinese medicine, the total industrial output of 105.92 million boxes of bottles, the sales revenue of 409.76 million Yuan, profit 64.82 million yuan, tax 40.69 million yuan. Many domestic pharmaceutical companies competing in the development of Chinese medicine powder injection industry situation, Harbin Pharmaceutical Group Co., Ltd. for the further expansion of technology and regulations